Erich M. Sturgis
University of Texas MD Anderson Cancer Center
401 Papers
2.7K Citations
Erich M. Sturgis is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 63, co-authored 383 publications. Previous affiliations of Erich M. Sturgis include University of Texas at Austin & University of Texas Southwestern Medical Center.
Chat about Author
Papers
PANDA: A prospective study of the prevalence of anal dysplasia among women with high-grade cervical, vaginal, and vulvar dysplasia or cancer (107)
S. Batman,Craig A. Messick,Andrea Milbourne,Ming Guo,Mark F. Munsell,Joël Fokom Domgue,Mila Pontremoli Salcedo,Ashish Deshmukh,Kristina R. Dahlstrom,Mallory Ogburn,Keith Sigel,Erich M. Sturgis,Elizabeth Y. Chiao,Kathleen M. Schmeler +13 more
TL;DR: In this paper , the authors describe the prevalence of anal dysplasia in women with cervical, vaginal, and vulvar dysplasias or cancer, and suggest that infection with high-risk human papillomavirus (HR HPV) is a risk factor for anal cancer.
Family history of cancer and risk of sporadic differentiated thyroid carcinoma.
TL;DR: Evidence suggests the existence of an inherited predisposition to development of differentiated thyroid carcinoma (DTC), and the association between sporadic DTC and family history of cancer is explored.
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
Stephen R. Grant,Katherine A. Hutcheson,Rong Ye,Adam S. Garden,William H. Morrison,David I. Rosenthal,G. Brandon Gunn,C. David Fuller,Jack Phan,Jay Reddy,Amy C. Moreno,Jan S. Lewin,Erich M. Sturgis,Renata Ferrarotto,Steven J. Frank +14 more
TL;DR: Patients reported outcomes following IMPT for oropharyngeal cancer demonstrates decreased swallowing function at completion of treatment with relatively rapid recovery by 10 weeks follow up and steady improvement through 2 years.
Sclerosing mucoepidermoid carcinoma of the salivary glands
TL;DR: In this article, the authors report four cases of Sclerosing MEC and evaluated them with Her-2/neu and MIB-1 to determine whether an association exists between the histologic grade and immunohistochemical findings.
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
Anderson Head,Anastasios Maniakas,Yelda Jozaghi,Mark Zafereo,Erich M. Sturgis,Shirley Y. Su,Ann M. Gillenwater,Paul W. Gidley,Carol M. Lewis,Eduardo M. Diaz,Ryan P. Goepfert,Michael E. Kupferman,Neil D. Gross,Amy C. Hessel,Kristen B. Pytynia,Marc-Elie Nader,Jennifer Wang,Miriam N. Lango,Kimberley L. Kiong,Theresa Guo,Xiao Zhao,Christopher M. K. L. Yao,Eric N. Appelbaum,Jennifer Alpard,Jose A Garcia,Shawn Terry,Jill E. Flynn,Sarah Bauer,Danielle M. Fournier,Courtlyn G Burgess,Cayla Wideman,Matthew Johnston,Chenxi You,Rolando de Luna,Liza M. Joseph,Julia Diersing,Kaitlin Prescott,Katherine Heiberger,Lilian Mugartegui,Jessica Rodriguez,Sara Zendehdel,Justin Sellers,Rebekah A Friddell,Ajay Thomas,Sonam J Khanjae,Katherine B Schwarzlose,Mark S. Chambers,Theresa M. Hofstede,Richard C. Cardoso,Ruth Aponte Wesson,Alex Won,Adegbenga O. Otun,Dan S. Gombos,Nagham Al-Zubidi,Katherine A. Hutcheson,G. Brandon Gunn,David I. Rosenthal,Maura L. Gillison,Renata Ferrarotto,Randal S. Weber,Ehab Y. Hanna,Jeffrey N. Myers,Stephen Y. Lai +62 more
TL;DR: Practices in surgical oncology had to change in response to resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of health care personnel.